Arbutus Biopharma CorporationABUSNASDAQ
LOADING
|||
EPS Growth Accelerating
Trending higher, above historical average, slight contraction.
Left:
||||
Year-over-year earnings per share growth rate
Latest
13.64%
↑ 142% above average
Average (9y)
-32.59%
Historical baseline
Range
High:78.73%
Low:-440.30%
CAGR
-6.7%
Structural decline
| Period | Value |
|---|---|
| 2024 | 13.64% |
| 2023 | 4.35% |
| 2022 | 36.99% |
| 2021 | 15.12% |
| 2020 | 68.03% |
| 2019 | -161.17% |
| 2018 | 33.12% |
| 2017 | 78.73% |
| 2016 | -440.30% |
| 2015 | 25.56% |